Journals of Gerontology Series A: Biological Sciences and Medical Sciences, Vol 53, Issue 1 M59-M63, Copyright © 1998 by The Gerontological Society of America

JOURNAL ARTICLE

Adverse drug events in hospitalized elderly

SL Gray, M Sager, MR Lestico and M Jalaluddin
School of Pharmacy, University of Washington, Seattle, USA. slgray@u.washington.edu

BACKGROUND: The study objectives were (a) to describe the occurrence, types, and preventability of adverse drug events (ADEs) in hospitalized patients 70 years of age and older; (b) to examine the association between potential risk factors and ADEs; and (c) to examine the relationship of an ADE occurrence and hospital length of stay (LOS) and functional decline. METHOD: Consecutive general medical admissions (n = 157) of community-dwelling persons were prospectively monitored daily for ADE occurrence. Admission assessment included demographic factors, cognition, preadmission medication use, and functional status. Discharge assessment included functional status. LOS, discharge diagnoses, and medication use during the hospitalization. RESULTS: Twenty-three patients (14.6%) experienced 28 probable ADEs, of which 54.2% (13/24) were judged to be potentially preventable. Patients experiencing an ADE had a significantly lower mean Mini-Mental State Examination score (23.6 +/- 4.3 vs 25.5 +/- 3.6, p = .039) and were prescribed significantly more new inpatient medications (4.0 +/- 2.3 vs 2.6 +/- 1.7, p = .01) compared to non-ADE patients. Age, gender, functional status prior to admission, percent with more than four active diagnoses, or number of preadmission medications were not associated with ADE status. Upon discharge, 50.0% of ADE patients experienced a decline in one or more activities of daily living (ADLs), compared with 24.1% of non-ADE patients (p = .017). ADE patients had a longer LOS (8.7 +/- 4.9 vs 6.6 +/- 3.0 days, p = .022) compared to non- ADE patients. CONCLUSIONS: ADEs were associated with number of new inpatient medications and admission cognitive status, but not demographic, disease, or physical function variables. Patients experiencing an ADE were more likely to experience a longer LOS and to decline in ADL function. ADEs may be one factor contributing to functional decline during hospitalization. Future research in this area should include larger samples and multivariable analyses controlling for potential confounders.

This article has been cited by other articles:

				S. Phansalkar, J. M. Hoffman, J. R. Nebeker, and J. F. Hurdle Pharmacists versus nonpharmacists in adverse drug event detection: A meta-analysis and systematic review Am. J. Health Syst. Pharm., April 15, 2007; 64(8): 842 - 849. [Abstract] [Full Text] [PDF]

				J. L. Schnipper, J. L. Kirwin, M. C. Cotugno, S. A. Wahlstrom, B. A. Brown, E. Tarvin, A. Kachalia, M. Horng, C. L. Roy, S. C. McKean, et al. Role of Pharmacist Counseling in Preventing Adverse Drug Events After Hospitalization. Arch Intern Med, March 13, 2006; 166(5): 565 - 571. [Abstract] [Full Text] [PDF]

				A. Corsonello, C. Pedone, F. Corica, C. Mussi, P. Carbonin, R. Antonelli Incalzi, and for the Gruppo Italiano di Farmacovigilanza nell'A Concealed Renal Insufficiency and Adverse Drug Reactions in Elderly Hospitalized Patients Arch Intern Med, April 11, 2005; 165(7): 790 - 795. [Abstract] [Full Text] [PDF]

				E. J Thomas and T. A Brennan Incidence and types of preventable adverse events in elderly patients: population based review of medical records BMJ, March 18, 2000; 320(7237): 741 - 744. [Abstract] [Full Text]